Medotrax offers BraincheX, a digital platform for cognitive assessment and patient-reported outcomes, to aid in early dementia diagnosis. The platform provides scalable digital cognitive assessments and tools for acquiring real-world neurological data.
Funding
Funding not disclosed
Founders
Product
Problem
The increasing global prevalence of dementia, coupled with the growing availability of novel therapeutics, highlights the need for precise and scalable diagnostic methods to facilitate early diagnosis and maximize the number of individuals who can benefit from treatment. Traditional diagnostic methods often lack the precision and scalability required for widespread early detection of cognitive decline.
Solution
Medotrax offers BraincheX, a cloud-based digital platform that delivers precise and scalable cognitive assessments and patient-reported outcome surveys to support clinical research and healthcare in neurology. BraincheX utilizes advanced digital technology to provide reliable cognitive assessments, enabling healthcare providers to detect signs of cognitive decline early and streamline patient care. The platform is designed for quick and easy administration, specifically targeting the early diagnosis of Alzheimer's disease, and is also available as an iOS app for increased accessibility. Medotrax's surveys, such as the Subjective Cognitive Decline Questionnaire (SCDQ) and Depression Assessment, are designed to provide actionable insights for research and healthcare providers, ensuring ease of use and accessibility, even for users with vision impairments or other limitations.
Target Audience
Medotrax's primary users are healthcare providers and researchers in neurology focused on early dementia diagnosis, treatment, and research.
Features
- Clinically validated digital assessments ensuring accurate results and near-instant analytics
- Gamified experience to create an engaging and interactive testing environment
- Inclusive and accessible design for people with cognitive, motor, or behavioral difficulties
- Language-independent testing to ensure language barriers do not impede accurate assessments
- Comprehensive cognitive assessments covering all relevant cognitive domains
- Vision-friendly survey design optimized for users with vision impairment, featuring enhanced visibility and intuitive navigation
- Surveys available in multiple languages to ensure accessibility to a global user base
- Cloud-based solution hosted in the European Union, fully compliant with EU GDPR, KRITIS, and C5 standards